FTIH Study With GSK958108

• Status: Completed
• Trial end date: 2008-08-22

Summary

This study is the first administration of GSK958108 to man. The study will evaluate the safety, tolerability and pharmacokinetics of single ascending doses of GSK958108 and evaluate the effect of food on GSK958108 pharmacokinetics

• Phase: Phase 1

Details

• Lead Sponsor: GlaxoSmithKline